Company / EPS (Diluted)
OCULAR THERAPEUTIX, INC EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.02
FY2025
5-year range
-$2.56 / -$0.97
FY2021-FY2025
Trend
-5.2%
vs FY2024
Sector context
#84 of 204
Health Care
What the data says
At $-1.02, OCULAR THERAPEUTIX, INC's eps (diluted) ranks #84 of 204 in the Health Care sector. EPS (Diluted) has fluctuated over the past 10 years, ranging from $-2.69 in FY2016 to $-0.45 in FY2019.
Based on SEC 10-K filings.
-1.02 in FY2025.
Declined from $-0.98 to $-1.02 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#84 of 204 in Health CareTop 41% of 204This company -$1.02 Sector average -$0.98
▼
-4.1% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 5.2% year-over-year.
- Ranks #84 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2019.
- Lowest eps (diluted) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.02 | -5.2% |
| FY2024 | -$0.97 | +1.0% |
| FY2023 | -$0.98 | +61.7% |
| FY2022 | -$2.56 | -34.0% |
| FY2021 | -$1.91 | +0.0% |
| FY2020 | -$1.91 | -324.4% |
| FY2019 | -$0.45 | +75.0% |
| FY2018 | -$1.80 | -5.3% |
| FY2017 | -$1.71 | +36.4% |
| FY2016 | -$2.69 | +47.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026